跳至主要内容
临床试验/IRCT201012264784N2
IRCT201012264784N2已完成未知

Effect of prophylactic administration of fibrinogen concentrate on volume of transfused packed RBC during and after totla hip arthroplasty in sina hospital during 2011-2012.

Tehran University of Medical Siences- Vice-chancellor for reseach0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 75 years(—)
性别
All

入选标准

  • 1- patients aged 35-75 years old scheduled for total hip arthroplasty
  • 2-ASA physical status I and II
  • 3-hemoglubin level more than 10
  • 4-MET more than 4
  • 5-completely fill and sign the informed consent.
  • Exclusion criteria:
  • 1-ASA class more than 3
  • 3-pregnancy
  • 4-history of allergic reaction to blood products specially fibrinogen concentrate
  • 5-history of DVT and pulmunary emboli and any embolic events.
  • 6-recent MI and CVA during last 6 month
  • 7-known cases of coagulopathy and thrombocytopenia.

排除标准

  • 未提供

研究者

发起方
Tehran University of Medical Siences- Vice-chancellor for reseach

相似试验